Jump to content

Harrison Stafford

Legacy Members
  • Posts

    2675
  • Joined

  • Last visited

Everything posted by Harrison Stafford

  1. Took back some of the rise RVPH had yesterday…obviously, somebody knew this was coming… and they needed to do it. Not the end of the world as there were 29.8 million shares issued and almost 5 million of that was closely held. Stiflel resumed coverage on EOSE with a price target of $6. EOSE +.31 to $2.20.
  2. Maybe, Blanco would be better utilized if he was in the bullpen.
  3. RVPH +.30 to $1.10. She’s waking up.
  4. Thank the Lord we didn’t waste another solid start from Kikuchi. 5 2/3 innings, one earned run, and seven strikeouts.
  5. Indeed, Kikuchi has been nails so far (hope this doesn’t jinx him tonight).I suppose I should be happy for Wags. Performing well on the big stage.
  6. Since joining the Jays, Will Wagner is 8 for 15 batting a nifty .533. That gives me discomfort.
  7. Look at the bottom third of the Astros order today. No wonder they aren’t doing anything with the bats.
  8. Re: IBRX, GERN, UUUU, AMYZF (which is finally starting to generate revenue), EOSE, & RVPH, I believe in their science until I see something to tell me otherwise. All these companies have great promise, but it doesn’t happen overnight and the market will go through its ups and downs until it’s clear they’ve arrived. I made large bets and am swinging for the fences. The swings in value you have to withstand can be hard to take, but unless you don’t think they can get it done, you’re in i6 for the duration.
  9. Most of them don’t have mugshots…..presumably.
  10. McCormick batting less than .200 with two runners in scoring position with two outs and we don’t PH. Madness.
  11. Steal home. I don’t know if we’re gonna get a run any other way.
  12. Kikuchi deserves some love. He’s given us three solid starts with an ERA of 2.70.
  13. It’s always been this way in aggyland. Over the years, reporters have been moved to other beats because they didn’t follow the party line. God help you if you asked a tough question.
  14. IBRX only started receiving revenue from the sales of Anktiva during the last 30 days of Q2. The next quarter should provide a better guide to revenue generation. I’d add that Anktiva is the new standard of care for treating bladder cancer. This drug is doubling the survival rate of advanced lung and pancreatic cancer patients. They have a principal owner who is a billionaire and willing to spend his money to see them get to market. I think what they have is a moneymaker and they’re going to expand to the EU by the end of the year. I made a very large bet on the stock, but I like my chances.
  15. Well, the most often used pick up line I heard at the Dixie Chicken that summer was, “Hey, you wanna match molars?”
×
×
  • Create New...